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Abstract 
The double electrode voltage-clamp technique was used to study voltage-dependent Ca*’ channels in Pleurodeles oocytes. From a holding potential 
of -80 mV, Ba-current (ZBa) (recorded in Cl-free solution, Ba 2+ = 40 mM) activated at -36.7 + 4 mV, peaked at - 11.6 f 4 mV and reversed at 55 + 7 
mV (n = 24). This current activated slowly (rise time was 0.98 f 0.2 s; n = 14 at -10 mV) and was not inactivated. Cadmium (Cd”, 5OOpM) completely 
inhibited I,,. The effect of Cd2+ was dose-dependent (ECSo = 37 + 5pM; n = 5). Moreover, ZBa was insensitive to w-conotoxin (10pM) but interestingly 
this ZBa displayed dihydropyridine (DHP) sensitivity. Bay K 8644 (SpM), a DHP activator, increased the peak current amplitude in a dose-dependent 
manner (EC,,, = 5.9 f 0.6 PM; n = 10) and shifted the threshold and the maximum of current/voltage relationship towards negative potentials by 
-10 mV. Nifedipine (5 PM), a DHP antagonist, decreased Z,, by 80% at HP of -80 mV (EC,, = 1.2 + 0.2 PM; n = 6). We concluded that Pleurodeles 
oocytes possess High-Voltage Activated Ca” channels with properties similar to L-type Ca” channels. 
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1. Introduction 
A variety of oocytes produce action potentials when 
their membrane is depolarized. In invertebrates oocytes, 
the action potentials result from the activation of both 
Ca” and Na’ currents while in vertebrate oocytes, 
purely calcium or sodium dependent spikes are observed 
[ 1,2,3]. Ca*’ channel multiplicity has been extensively 
demonstrated in a variety of cell types [4,5] including 
oocytes and eggs [1,6]. In ascidian eggs, two different 
Ca*+ channels have been identified: one, the ‘high-volt- 
age-activated’ (HVA), so-called L-type Ca*’ channel 
(DHP-sensitive); the other one is a ‘low-voltage-acti- 
vated’ (LVA), so-called T-type Ca*’ channel [7]. In the 
immature oocytes from the starfish Mediaster, both 
HVA and LVA Ca*’ channels coexist [8]. However, only 
HVA Ca” channels have been recorded in Xenopus 
oocytes [9]. To date, there have been no electrophysiol- 
ogical studies on Ca*’ channels in Pleurodeles immature 
oocytes, while a rise of intracellular Ca2+ activity has 
been observed during progesterone induced maturation 
[lo]. With Ba*+ ions as charge carriers, we found HVA 
Ca*’ channel currents with very slower kinetics of activa- 
tion and inactivation. Interestingly, these currents are 
sensitive to dihydropyridines, agonist (Bay K 8644) and 
antagonist (nifedipine). 
2. Materials and methods 
2.1. Oocyte reparation 
All experiments were performed during the breeding season (Septem- 
ber to May) when Pleurodetes oocytes resumed meiosis with progester- 
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one treatment. Oocytes were dissected away from ovary of female 
Pleurodeles waltlii (urodele amphibian, from Laboratoire de Biologie 
du DCveloppement, USTL, France) anaesthetized with 1% MS 222 
(tricaine methanesulfonate; Sandoz) and prepared as reported previ- 
ously [I I]. Stage VI oocytes (diameter of 1.6 mm) were selected for 
electrophysiological measurements. Defolliculated oocytes could be 
maintained for 2-6 days at 19°C in control solution containing (ND 
96; in mM): NaC196, KC1 2, CaCl, 2 and HEPES [4-(2-hydroxyethyl)- 
I-piperazineethanesulfonic acid] 10, pH 7.2 with NaOH and supple- 
mented with 50 pg/ml gentamicin. Incubation medium was renewed 
daily. 
2.2. Eiectrophysiological measurements 
Electrophysiological measurements were performed using the stand- 
ard two microelectrode voltage-clamp technique with TEV-200 ampli- 
fier (Dagan Instruments, Minneapolis, MN). Stimulation of the prepa- 
ration, data acquisition and analysis were performed using the 
pCLAMP software (ver. 5.5, Axon Instrument, Burlingame, CA). 
Oocytes were placed in a recording chamber (300 ~1) and impaled with 
3 M CsCl-filled microelectrodes (0.2-l MQ). 
Drugs were applied externally by addition to the superfusate (gravity 
driven superfusion). We used a Cl free solution (CaMS; in mM): NaOH 
96, KOH 2, CaOH 2 and HEPES IO, pH 7.2 (methane sulfonic acid) 
in order to block the Cl currents. The main part of the outward K 
current was inhibited by using Cs instead of K in the recording elec- 
trodes and 4-aminopyridine (10 mM) was added in the CaMS and in 
the BaMS solutions. No fast Na current was detected in these oocytes. 
However, all extracellular Na was replaced by tetraethylamonium and 
tetrodotoxin (1OpM) was added. Thus, to record Ca” channel activity, 
oocytes were tested in the high barium methane sulfonate solution 
(BaMS, in mM): TEAOH 50, CsOH 2, BaOH 40 and HEPES 10, pH 
adjusted to 7.2 with methane sulfonic acid. 
2.3. Drugs 
Cadmium, 4-aminopyridine, tetraethylamonium and tetrodotoxin 
were purchased from Sigma (St. Louis, MO, USA) and were dissolved 
in water. The DHP agonist Bay K 8644 and antagonist nifedipine 
(Calbiochem, France) were dissolved in 50% ethanol to make concen- 
trated stock solutions (10 mM) and stored at -20°C. w-Conotoxin was 
purchased from Calbiochem (France) and was dissolved in water to 
make stock solution (IO mM). All final concentrations were obtained 
by appropriate dilution in BaMS solution. 
2.4. Analysis 
Ba-current was measured as the difference between the maximal 
inward current amplitude and the zero current level. Most data are 
expressed as the means (S.E.M.) (n = number of experiments). 
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3. Results 
The mean membrane potential from immature oocytes 
was -63 + 10 mV (n = 10) and the membrane capaci- 
tance was 0.19 + 0.04 ,uF (n = 16). 
3. I. Electrophysiological properties of the Ba-current 
&a) 
In a normal physiological bathing medium (ND 96), 
depolarization to +20 mV from a holding potential of 
-80 mV elicited an outward current (Fig. IA,). The per- 
fusion of a Cl-free solution (CaMS; Ca2’ = 2 mM) re- 
duced this outward current (Fig. lA,). This result sug- 
gests that a portion of outward current is carried by Cl 
ions. The perfusion of the high Ba*+ solution (BaMS; 
Ba” = 40 mM) blocked completely the remaining out- 
ward current and elicited an inward Ba-current (Fig. 
1 A,). Moreover, Pleurodefes oocytes developed a Ca” 
activated K’ current which activated about -40 mV. Fig. 
1B shows the Ca*’ activated K’ current elicited from a 
holding potential of -80 mV to - 10 mV during exposure 
to high Ca” solution (CaMS; Ca” = 20 mM). An in- 
ward current was elicited when Ca” (20 mM) was re- 
placed by Ba” (20 mM) (Fig. 1B). However, even in 
BaMS solution, a small outward current remained at 
above + 30 mV. 
This paper is based on recordings Ca*’ channel activ- 
ity in Pleurodeles oocytes. Fig. 1C shows typical waves 
of Z,, evoked for various depolarizations between -40 to 
+30 mV from a holding potential of -80 mV. The peak 
ZBa magnitudes were normalized for variation in oocytes 
size using oocytes membrane capacitance. The mean of 
ZBa density records during a test pulse to -10 mV from 
a holding potential of -80 mV was 0.86 & 0.21 +%lpF 
(n = 24). IBa density/voltage relationship is shown in Fig. 
1D. For test pulses of a 2 s duration, ZB, activated at 
-36.7 k 4 mV (n = 24), peaked at -11.6 & 4 mV (n = 24) 
and reversed at 55 + 7 mV (n = 24). However, in few 
oocytes no inward Ba-current could be recorded except 
in the presence of the DHP agonist (Bay K 8644) (data 
not shown). Thus, only a HVA Ca” channel is evident 
in the Pleurodeles oocytes. Using a 2 or 6 s pulses, we 
were unable to observe any inactivation of ZBa (data not 
shown). Furthermore, ZBa showed extremely slow inacti- 
vation requiring 3 min pulse duration (Fig. 1E). 
Further characterization of these Ca” channels has 
been focussed on the effect of various classical Ca*’ 
channel inhibitors or activators used to differentiate be- 
tween the different types of HVA Ca” channels. 
3.2. Effect of Cd’ on I, 
Among the many potent inorganic Ca” channel 
blockers, Cd’+ is of particular interest in a number of 
preparations. Fig. 2A shows effect of different concen- 
trations of Cd2+ on HVA Ba-current activated from -80 
mV to -10 mV. The reduction of ZBa by Cd2+ was dose- 
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Fig. 1. (A-E) Electrophysiological properties of ‘high-voltage activated’ 
calcium channel currents (using Ba*’ as charge carrier) in Pleurodeles 
oocytes. (A) Typical traces showing an outward current recorded: 
(I) in normal physiological medium (ND 96); (2) in the free Cl solution 
(CaMS; Ca*’ = 2 mM); and (3) the recovery of Zsa when superfused 
with high BaMS solution (0 Cl, 40 mM Bar+). The holding potential 
(k’s) was stepped from -80 mV to + 20 mV for 2 s. (B) Outward current 
elicited from Vh of -80 mV to -10 mV (0) in the high CaMS solution 
(0 Cl, 20 mM Car’). The substitution of external Ca2’ (20 mM) by Ba2’ 
(20 mM) elicited an inward Zsp (0). (C)Typical waveforms of I,,. From 
V, of -80 mV, Za* was evoked by test pulses to depolarization between 
-40 mV and -10 mV (left panel) and between 0 mV and +30 mV (right 
panel) presented in 10 mV increment. (D) Current/voltage relationship 
of the peak current normalized by the membrane capacitance. Mean 
ZBa density @A/pF) are plotted as a function of depolariza- 
tion f S.E.M. (n = 24). (E) Kinetics of activation and inactivation of 
ZBs. The waveforms of Isa evoked at -10 mV from V,, of -80 mV for 
3 min duration. 
dependent with an EC,, of 37 + 5 ,uM (n = 5; Fig. 2B). 
A complete block of ZBa was obtained in the presence of 
500 PM Cd*+ (Fig. 2A,B,C). Fig. 2C shows peak NV 
relationship determined in the absence and the presence 
of 500 ,uM Cd*+. 
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Fig. 2. (AC) Effects of various concentrations of Cd’+ on I,,. 
(A) Effect of Cd” (IO, 50, 100, 500 PM) on IBa. The holding potential 
was stepped from -80 mV to -10 mV for 2 s (Ctrl = control). (B) 
Cumulative dose/response r lationship of the inhibition of I,, by Cd*+. 
Each point is expressed as mean + S.E.M., n = number of oocytes. The 
dose of 50% inhibition is 37 I!Z 5 PM (n = 5). (C) Current/voltage rela- 
tionship of I,,, (0) before and (w) after perfusion of Cd’+ (500 ,uM). Vh 
was -80 mV, test pulses 2 s in duration and 10 mV in increment were 
applied every 40 s. 
3.3. Effect of w-conotoxin (w-cgTx) and 
dihydropyridines (DHP) on I, 
In many tissues, the entry of Ca’+ ions can be modu- 
lated by diverse classes of organic compounds that have 
proved their efficiency as ligands to purify and character- 
ize Ca2+ channels. 
Sensitivity to w-cgTx and l-4 dihydropyridines has 
been used to identify different subtypes of Ca*’ channels. 
w-cgTx has no effect on L-type Ca2’ channels in smooth, 
cardiac and skeletal muscle but reduces the N-type Ca2’ 
channels [12]. When w-cgTx was applied in concentra- 
tions with a saturating block in other preparations (10 
,uM), in Pleurodeles oocytes, no effect on IBa was ob- 
served (n = 12, data not shown). 
The primary site of action of 14 dihydropyridines is 
H. Ouudid et al. I FEBS Letters 351 (1994) 5862 
thought to be L-type Ca2’ channels [13]. Bay K 8644, a 
dihydropyridine agonist, has been shown to promote 
Ca2+ current [14,15]. External application of Bay K 8644 
(5 ,uM) increased the peak inward current at test poten- 
tial from -80 mV to -20 mV (Fig. 3A). The effect of Bay 
K 8644 on IBa was dose-dependent with an EC,, of 
5.9 & 0.6 FM (n = 10) (Fig. 3B). The threshold and the 
maximum of the I/V relationship (Fig. 3C) shifted about 
- 10 mV in the negative direction consistent with the shift 
in voltage dependence of activation seen in heart [ 16,171, 
neurones [18] and skeletal cells [19]. 
The effect of the DHP antagonist nifedipine on IBa is 
shown in Fig. 3. The peak inward current was signifi- 
cantly reduced by nifedipine (5 ,uM) at test potential -20 
mV (Fig. 3D). The effect of nifedipine on IBa was dose- 
dependent with an ECso of 1.2 + 0.2 PM (n = 6) (Fig. 
3E). By contrast to the effect of Bay K 8644, no leftward 
shift in the I/V curve was obtained with nifedipine (Fig. 
3F). 
4. Discussion 
The main result of our study is the existence of HVA 
Ca” channel DHP-sensitive in the Pleurodefes oocytes. 
These HVA Ca2’ channels, like others found in various 
preparations [5,13] can be distinguished by the activation 
voltage (= -30 mV) and their sensitivity to the inorganic 
blocker Cd’+ (EC,, = 37 + 5 PM, Fig. 2). Moreover, IBa 
reported here was modulated by DHP agonist and an- 
tagonist. Bay K 8644, a DHP activator, enhances the 
peak IBa and induces a left shift by about - 10 to - 15 mV 
of both threshold and the maximum of the NV curve. 
Nifedipine, a DHP antagonist, reduces IBa by = 80% at 
HP of -80 mV and induces no leftward shift in the I/V 
curve (Fig. 3D-F). Taken together, these results agree 
well with those obtained on cardiac [16,17] and skeletal 
L Ca2’ channels [ 19,201. However, some discrepancies 
can be observed between our results and those derived 
from cardiac and skeletal cells: (i) the DHP concentra- 
tions used to obtained the half maximum effect in our 
experiments are lOO-lOOO-fold higher than those re- 
ported in cardiac (- lo-’ M for both nifedipine and Bay 
K 8644 [14,21] and in skeletal cells (- lo-’ M) [ 191. 
However, it should be noted that these (EC,,) from car- 
diac and skeletal cells were obtained in the presence of 
the normal external calcium while in our experiments we 
use a 40 mM external Ba2+ concentration; (ii) in skeletal 
muscle, Bay K 8644 shifted only the threshold of I/V 
curve [19] while in our study both the threshold and the 
peak of the I/V curve are shifted in the presence of Bay 
K 8644. 
So, what types of channel mediates I,, in Pleurodeks 
oocytes? In terms of the voltage-dependent properties 
and sensitivity to DHP (agonist and antagonist), this 
channel resembles the L-type Ca*’ channel reported in 
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Fig. 3. (A-F) Regulation of I,, by DHPs agonist (Bay K 8644) and 
antagonist (nifedipine). (A) Individual Ba-current traces evoked by a 
depolarizing pulse from -80 mV to -20 mV; (0) Ian recorded in the 
control solution and (m) maximal increase of Z,, induced by perfusion 
with the same solution containing Bay K 8644 (5 PM). (B) Cumulative 
dose/response relationship of increase I,,, by Bay K 8644. The dose of 
50% increase is 5.9 f 0.6 PM (n = 10). Each point is expressed as 
mean rf: S.E.M., n = number of oocytes. (C) Current/voltage relation- 
ship traced from I’,, -80 mV (0) in absence and (u) in presence of Bay 
K 8644 (5 PM). The threshold and the maximum of faa were shifted by 
about -10 mV towards negative potentials. (D) Individual Ba-current 
traces recorded from -80 mV to -20 mV, (0) I,, control, (A) IBa in the 
presence of nifedipine (5 PM). (E) Cumulative dose/response relation- 
ship of decrease IBa by nifedipine. The dose of 50% decrease is 1.2 f 0.2 
PM (n = 6). Each point is expressed as mean f S.E.M., n = number of 
oocytes. (F) Current/voltage relationship traced from Vh -80 mV (0) 
in absence and (A) in presence of nifedipine (5 PM). 
various tissues: cardiac [17,22], neuronal [18,23] and 
skeletal [20,24]. In terms of the activation kinetic (time 
to peak, 0.98 + 0.2 s at -10 mV), ZBa closely resembles 
the slow activating DHP-sensitive Ca*’ channel reported 
in skeletal muscle [24,25]. In terms of inactivation kinet- 
ics (non-inactivating Z,,), Z,, is similar to the fast rising 
non-inactivating DHP Ca” channel reported in dysgenic 
skeletal muscle [26]. 
Recently, molecular biological studies have revealed 
that the HVA Ca” channel is a protein complex contain- 
ing a,, a,/S, /3 and y subunits [27,28]. Recent studies have 
revealed a diversity among L-type Ca2’ channels arising 
from: (i) multiples genes encoding the pore forming a,- 
subunit; and (ii) various genes (at least 4) encoding the 
auxilliary B-subunit. While it is already known that the 
a,-subunit plays a major role in determining the activa- 
tion kinetics [27,28], the auxilliary subunits, in particular 
p-subunit plays a major role in determining both the 
kinetics and voltage dependence of the inactivation proc- 
ess. In L-cells, stable expression of skeletal muscle a, 
alone was sufficient to generate a slowly activating and 
inactivating Ca2+ channel [29,30]. The coexpression of 
skeletal muscle /I with skeletal muscle a, markedly accel- 
erate both the activation and inactivation kinetics 
[29,30]. As reported here Z,, was activated slowly and did 
not inactivate may indicate that the L-type Ca” channels 
in Pleurodeles oocytes contain a,-subunit (DHP sensi- 
tive) but a few and/or no B-subunit. 
Our study argues an heterogenecity in Ca2’ channel 
types between amphibian oocytes and more generally 
between vertebrate and invertebrate oocytes: (i) T and L 
Ca2’ channels in ascidian eggs and starfish oocytes [7,8]; 
(ii) HVA Ca*’ channels different from the four subtypes 
known in Xenopus oocytes [9,31,32] and (iii) a DHP- 
sensitive HVA Ca*’ channel subtype in the Pleurodeles 
oocytes. These Ca” channels (DHP-sensitive) 
in the Pleurodeles oocytes might have a physiological 
involvement in the regulation of free internal Ca con- 
centration during meiosis, fertilization and develop- 
ment. 
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